...

...

Dr Derashodian is a radiation oncologist working at BC Cancer Kelowna. Centre Intégré de Cancérologie de la Montérégie, at Charles LeMoyne hospital. She graduated from Université de Montreal’s medical school in 2005. She then completed her residency in radiation oncology at Université Laval. She pursued her academic training at University of Miami with a fellowship in Urologic cancers under the supervision of Dr Alan Pollack. She then started her practice at Centre Intégré de Cancérologie de la Montérégie, at Charles LeMoyne hospital, and gained expertise in general brachytherapy.  Her main areas of expertise include urologic, gynecologic, and skin cancer, as well as general brachytherapy.

Slobodan Devic finished his studies of physical sciences at the Faulty of Physics, University of Belgrade, Yugoslavia in 1989.  At the same university, he obtained his M.Sc thesis working in the experimental non-ideal plasma physics in 1991 and his Ph.D thesis in the solid state physics working on new high temperature super conducting materials in 1997.  He entered the medical physics field in 1998 as a post doc at Mallinckrodt Institute of Radiology in Saint Louis, Missouri. Working as a member of Jeffrey Williamson’s group, he was developing experimental techniques for verification of Monte Carlo dose calculations for brachytherapy applications using plastic scintillator materials.  In February 2000, he enrolled the AAPM accredited residency program at Medical Physics Unit of McGill University. As of March 2002 he became a staff member in Radiation Oncology Department of the Montreal General Hospital. In December 2008, he moved to the Jewish General Hospital and was put in charge of establishing brachytherapy program with CT-simulator within brachytherapy suite.   Apart from his clinical duties, his research interests revolve around image guided pre-operative endorectal brachytherapy, GafChromic film dosimetry, and PET/CT based treatment planning. As of 2018, he holds an appointment of Associate Professor with Department of Oncology at McGill University.

...

...

...

...

With an MD degree from the Université de Montréal, Dr. Marjory Jolicoeur founded Curietherapies in 2012, a non-profit organization that she still presides over today. A renowned radiation oncologist, she did her residency at Université de Montreal in 1996, before completing a brachytherapy fellowship at the Centre Georges-François Leclerc located in Dijon (France). In 1997, she started working at the department of Radiation Oncology of Université de Montréal, where she still teaches. A mere two years later, she was appointed medical consultant for all planning, construction and equipment selection processes of the new Radiation Oncology department of Hospital Charles-Le Moyne. She innovates by equipping the department with a suite and a comprehensive image-guided brachytherapy program. As a brachytherapy specialist, she has special research interests in its application to pathologies such as breast, genitourinary and gynecologic cancers. Her main focus is on the development of image guided implant procedures, the use of MRI in brachytherapy and the precision delivery of conformal high dose rate brachytherapy. She also teaches brachytherapy nationally and internationally. 

...

...

...

Fellowship en curiethérapie; Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA MSc médecine expérimentale; Faculté de médecine, University Laval, Québec, Québec “Diplôme d’étude supérieurs en radio-oncologie”; University Laval, Québec, Québec Doctorat en médecine; Faculté de médecine, Université Laval, Québec, Québec Bachelier en Pharmacie; École de pharmacie, Université Laval, Québec, Québec

A obtenu son M.SC. de l’université McGill en physique du solide en 1982. Après plusieurs années d’enseignement, elle s’est spécialisée en physique médicale appliquée à la radio-oncologie. Elle travaille dans cette spécialité depuis 1989. Elle a fait sa certification MCCPM et FCCPM en 2000 (membre et fellow du Collège canadien des physiciens en médecine). Elle a travaillé 2 ans à l’hôpital de Chicoutimi, 9 ans au Centre hospitalier de l’université de Montréal et 10 ans à l’hôpital Maisonneuve-Rosemont. Durant ces années, elle a eu la chance de toucher les différents secteurs de la physique médicale en radio-oncologie : acceptation des appareils de traitement en téléthérapie, modélisation des plans de traitement, dosimétrie de techniques spéciales, radioprotection et curiethérapie. Depuis 2010, elle est responsable de la physique médicale section curiethérapie à l’hôpital Charles LeMoyne.

Dr Nadia Octave was educated and trained in France inbiomedical engineering with a specialization in radiationphysics and imaging. She has a solid track career in medicalphysics and in brachytherapy specifically, starting at theCurie Institute where she was trained as a physics resident.Her latest career challenge: the construction fromblueprints to full operation of a new cancer centre with theimplementation of a brachytherapy program along with theradiation protection program. Dr Octave is a strong believerof the inclusive and equitable collaborative approach inradiation oncology, and even more while establishing abrachytherapy program.

...

...